Apimeds Pharmaceuticals US Inc.
Industry: Health Care – Biotechnology: Pharmaceutical Preparations
Stock Symbol: APUS – AMEX
Animal Usage: Animal Testing, By-product
Our Opinion
Animal Exploitation (Testing): Yes Link: https://www.sec.gov/Archives/edgar/data/1894525/000121390025032206/ea0237283-10k_apimeds.htm Short Description: The company’s lead product, Apitox, is a bee venom-based toxin, meaning its final product is an animal by-product (venom) derived from the Apis mellifera (honeybee). Furthermore, as a clinical stage biopharmaceutical company developing a new drug, they are subject to regulatory requirements that necessitate preclinical animal testing. Exact Quote from Link: “Apitox is a purified, pharmaceutical grade venom (bee venom), of the Apis mellifera, or western honeybee, which is classified by the FDA as an active pharmaceutical ingredient (“API”).” (This confirms the direct use of an animal by-product—bee venom—as their active ingredient.)